Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

Lumpy skin disease virus different from 2019 version

Finding raises questions about efficacy of the new vaccine

The Hindu

Fauci warns of anti-vaxxer attitude beyond COVID

WASHINGTON — President Joe Biden’s top medical adviser warned in an interview with the Financial Times that a broad refusal of vaccines against COVID-19 may undermine efforts to immunize children and contain future illness outbreaks.

Tribune News Service

Younger adults aren’t getting boosted — here’s why that could be a huge problem

Just because you aren't at high risk for Covid-19 doesn't mean you don't need a booster. An immunologist explains why boosters are key for healthy young adults.

Inverse

From analysis to the latest developments in health,
read the most diverse news in one place.

Brazil approves Pfizer vaccine for children as young as six months

Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years, the government body said in a statement Friday night.

Reuters

Nearly 200,000 Illinoisans have received the updated COVID booster

In Chicago, 65% of the doses administered to date have gone to white residents.

Chicago Sun-Times

Wales sees another dramatic fall in its Covid infection rate but another part of the UK sees a rise

Less than 1% of the Welsh population now has Covid

Wales Online

Southern states’ lackluster monkeypox efforts leave LGBTQ+ groups going it alone

Dan DeChellis started looking for a monkeypox vaccine around July Fourth but was unable to find a place that offered one in Orlando, Florida, where he lives.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Where you can get the monkeypox vaccine in Greater Manchester next week

More clinics will run in the region over the next two weeks

Manchester Evening News

Commentary: You might need a COVID booster yearly. But this virus is still nothing like the flu

Should everyone eligible get the new omicron-specific COVID booster? Yes, absolutely. But we should not get lulled into the illusion that the fight against COVID is over and now comparable to preventing the flu.

Los Angeles Times

Commentary: Will vaccine fatigue affect how many people get the bivalent booster?

Pfizer’s and Moderna’s bivalent boosters, which are now available to many age groups, offer protection against the original COVID-19 virus plus the BA.4 and BA.5 omicron subvariants. Is the nation ready for yet another COVID-19 vaccine shot?

Chicago Tribune

Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from the pivotal Phase 3 trial assessing the safety, tolerability, and immunogenicity of its investigational pentavalent meningococcal vaccine (MenABCWY) in healthy individuals 10 through 25 years of age. The trial met all primary and secondary endpoints. Pfizer shares traded in a range of $45.7…

Benzinga

Queen Elizabeth II's death sparked a slew of misinformation. Here's what you need to know

Following the death of the Queen, rumours began to spread online on everything from the nature of her passing to the colour of the BBC's banner.

ABC News

Breakthrough malaria shot needs more funding

It took scientists 30 years to create the first malaria vaccine, approved by the World Health Organization in 2021. A second, even better one is now almost ready to be deployed against the disease. Governments and philanthropies should be stepping up their funding to global health partners so they can…

Bangkok Post

The Silver Lining For Pfizer, Moderna In This Month's IBD/TIPP Poll

Vaccine stocks Pfizer and Moderna could see some upside from their new Covid boosters, according to the September IBD/TIPP Poll.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

This 1 Stock Pays You Just for Owning It

Leading pharmaceutical company Pfizer (PFE) did exceptionally well during the pandemic thanks to the high demand for its COVID-19 vaccine, and it still has enough growth prospects. The company’s focus on strengthening its pipeline via business acquisitions, product development, and approvals is expected to deliver impressive growth in the upcoming…

Tribune News Service

Noah Feldman: A Texas judge just took religious ‘freedom’ too far

The long march of religious liberty exemptions is gaining speed. The people who brought you contraceptive care exemptions and COVID rule and vaccine exemptions have now moved on to insurance for anti-HIV drugs. Last week, a federal district court held that a Christian employer is entitled to an exemption from…

The Independent UK

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

‘Stealthy’ new Covid variant can reinfect you every month

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Pandemic fatigue threatens COVID-19, monkeypox funding requests

As the Biden administration asks Congress for additional federal dollars to fight infectious diseases, it faces a conundrum: pandemic fatigue.

Benzinga

Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ:TCON) lead asset envafolimab (KN035) for patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) who have progressed on one or two prior lines of chemotherapy. TRACON shares…

The Conversation

Malaria vaccine: the road has been long and tortuous, but we're getting there

A vaccine candidate, called R21, has been shown to be up to 80% effective at preventing malaria in young children, according to the latest trial results.

Wales Online

TikTok riddled with 'misleading information about Covid, Russia and climate change'

TikTik said it did 'not allow harmful misinformation, including medical misinformation, and we will remove it from the platform'

Roll Call

Pandemic fatigue threatens COVID-19, monkeypox funding requests - Roll Call

COVID-19 hospitalizations and deaths are down, but White House argues that pandemic money is needed for future public health threats.

The Hindu

IISc scientists develop gold-coated vesicles to fight tuberculosis

The spherical vesicles, which can be delivered to immune cells, are expected to potentially trigger an immune response

Daily Mirror

Covid booster: How to book your autumn vaccine as infections begin to creep up

26 million people will be eligible for the coronavirus booster jab this winter, with the elderly and some frontline workers first in the queue to get protected.

1 … 121 122 123 124

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.